EFTA02104914

To: From: James Meiskin Sent Wed 5/21/2014 10:05:40 PM Subject Re: Confidential Confirmed. Thank you Sent from my iPhone On May 21, 2014, at 5:51 PM wrote: Jeffrey's home, 9 East 71st Street between 5th and Madison... 5pm would be great. On May 21, 2014, at 5:14 PM, James Meiskin wrote: That will work. Do you have a time and location in mind? Thank you, James Sent from my iPhone On May 21, 2014, at 10:25 AM, wrote: Great. Would Sunday June 1st work? Sent from my iPhone On May 21, 2014, at 9:47 AM, James Meiskin wrote: Of course. Please get me dates that work for Jeffrey, and I will have David fly in from CA to meet him withi r,sure. Hope your well Best, James Sent from my iPhone On May 21, 2014, at 9:41 AM, M la• wrote: HI James....below is Jeffrey's response: EFTA_R1_00718225 EFTA02104914 im not in ny until June but happy to see you both after Might it be possible to schedule something the beginning of June? On May 21, 2014, at 9:23 AM, "James Meiskin" wrote: Jeffrey, David Carter (Company information is attached), is in NY today and tomorrow morning, and I felt that it could be beneficial and timely for you to further learn about this opportunity if there was interest on your end. Please take a moment to review the attached material. and let me know if you would like to meet while David is in NYC. Best Regards, James Dear James, Like I have said in an earlier email. I am looking EFTA_R1_00718226 EFTA02104915 for an "investi ng partner " to match (50%/S 0%) the money Russian Ventur e Capital plans to invest in USA based Biotech nology. They will provide half of the capital to develop a variety of technol ogies that are of interest to their country . For their investm ent they get comme rcializat ion rights to the EFTA_R1_00718227 EFTA02104916 technol ogies they finance for Russia and the CIS. For us, on the USA side, this is a major source of capital to start a series of compan ies that have great potenti al as therape utic technol ogies, and we get comme rcializat ion rights for the USA, and rest of the world market s. Basicall y, we get the rights EFTA_R1_00718228 EFTA02104917 that are valuabl e to us at "half price". Over the next several years our plan is to identify seven/e ight technol ogies that are worthy of develop ment. RVC has already agreed to finance the first (MAJI) and is looking at the next two—P redictio n Bioscie nces, and Ovation Bio. I have several more currentl y in EFTA_R1_00718229 EFTA02104918 diligenc e. (The original Investo r Present ation made in Mosco w is attache d) So, I am looking for a source of capital that thinks this is an interest ing investm ent theme, and is willing to conside r the idea as someth ing they might want to implem ent. My belief is that there is more money in NYC, EFTA_R1_00718230 EFTA02104919 seeking an investm ent home, then there are "quality investm ent ideas". I could be wrong, but I have to believe that people running a lot of capital in New York would want to hear new, creative ,and GOOD new investm ent ideas. I think this idea is the kind of idea that is worth a look, and worth serious EFTA_R1_00718231 EFTA02104920 conside ration. I think we are talking $150M over a five year horizon Best, David David W. Carter Preside nt—Da Cart Capital LIC <DaCart Presentation.pptx EFTA_R1_00718232 EFTA02104921